Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Bsteh

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Biomolecules|September 28, 2021
Measuring Treatment Response in Progressive Multiple Sclerosis-Considerations for Adapting to an Era of Multiple Treatment OptionsNik Krajnc, Thomas Berger, Gabriel Bsteh
Cephalalgia : an International Journal of Headache|September 2, 2020
Refractory short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing responsive to anti-calcitonin gene-related peptide monoclonal antibodies: A case reportGabriel Bsteh, Christian Bsteh, Gregor Broessner
Frontiers in Neurology|September 13, 2021
Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic ReviewNik Krajnc, Gabriel Bsteh, Thomas Berger
Current Opinion in Neurology|April 8, 2026
Assessing treatment response in multiple sclerosisFabian Föttinger, Nik Krajnc, Gabriel Bsteh
Current Pharmaceutical Design|February 1, 2022
Diagnostic Approach and Treatment Regimens in Adult Patients Suffering from Antibody- mediated or Paraneoplastic EncephalitisStefan Macher, Gabriel Bsteh, Thomas Berger, et al.
Pharmacological Reviews|May 8, 2024
Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple SclerosisGabriel Bsteh, Assunta Dal Bianco, Tobias Zrzavy, et al.
Plos One|August 2, 2019
Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosisRainer Ehling, Gabriel Bsteh, Andreas Muehlbacher, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 5, 2022
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk ManagementNik Krajnc, Gabriel Bsteh, Thomas Berger, et al.
Biomedicines|November 11, 2022
Immunosenescence in Neurological Diseases-Is There Enough Evidence?Paulus S Rommer, Gabriel Bsteh, Tobias Zrzavy, et al.
Annals of Clinical and Translational Neurology|August 7, 2023
Clinical scales in autoimmune encephalitis-A retrospective monocentric cohort studyStefan Macher, Gabriel Bsteh, Romana Höftberger, et al.
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Biomolecules|September 28, 2021
Measuring Treatment Response in Progressive Multiple Sclerosis-Considerations for Adapting to an Era of Multiple Treatment OptionsNik Krajnc, Thomas Berger, Gabriel Bsteh
Cephalalgia : an International Journal of Headache|September 2, 2020
Refractory short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing responsive to anti-calcitonin gene-related peptide monoclonal antibodies: A case reportGabriel Bsteh, Christian Bsteh, Gregor Broessner
Frontiers in Neurology|September 13, 2021
Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic ReviewNik Krajnc, Gabriel Bsteh, Thomas Berger
Current Opinion in Neurology|April 8, 2026
Assessing treatment response in multiple sclerosisFabian Föttinger, Nik Krajnc, Gabriel Bsteh
Current Pharmaceutical Design|February 1, 2022
Diagnostic Approach and Treatment Regimens in Adult Patients Suffering from Antibody- mediated or Paraneoplastic EncephalitisStefan Macher, Gabriel Bsteh, Thomas Berger, et al.
Pharmacological Reviews|May 8, 2024
Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple SclerosisGabriel Bsteh, Assunta Dal Bianco, Tobias Zrzavy, et al.
Plos One|August 2, 2019
Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosisRainer Ehling, Gabriel Bsteh, Andreas Muehlbacher, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 5, 2022
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk ManagementNik Krajnc, Gabriel Bsteh, Thomas Berger, et al.
Biomedicines|November 11, 2022
Immunosenescence in Neurological Diseases-Is There Enough Evidence?Paulus S Rommer, Gabriel Bsteh, Tobias Zrzavy, et al.
Annals of Clinical and Translational Neurology|August 7, 2023
Clinical scales in autoimmune encephalitis-A retrospective monocentric cohort studyStefan Macher, Gabriel Bsteh, Romana Höftberger, et al.
Pageof 17